Clinical Trials Logo

Prediabetic State clinical trials

View clinical trials related to Prediabetic State.

Filter by:

NCT ID: NCT05247437 Not yet recruiting - Obesity Clinical Trials

Digital Lifestyle Intervention For Diabetes/Pre-Diabetes

Start date: February 19, 2022
Phase: N/A
Study type: Interventional

The study aims to evaluate the acceptability, feasibility, and preliminary efficacy of a digital lifestyle intervention, called Fitness Digital (FitD), for individuals with prediabetes or type 2 diabetes.

NCT ID: NCT05245825 Recruiting - Prediabetic State Clinical Trials

Flaxseed Supplementation in Prediabetic Adults (LINAPRED)

LINAPRED
Start date: November 20, 2021
Phase: N/A
Study type: Interventional

Prediabetes is the term used to describe the condition where blood glucose level is higher than normal but lower than the diagnosis criteria of type 2 diabetes mellitus (T2DM). This condition confers a high risk for the development of T2DM and other diseases. Prediabetes could be reversible with lifestyle modifications, which include medical-nutrition therapy. Within these modifications, a healthy diet high in fiber and sources of alpha-linolenic acid is recommended. Flaxseed is a seed that is considered a functional food because it can provide health benefits due to its high content of fiber, alpha-linolenic acid, and lignans, these components could improve glycemic control in prediabetes patients by different mechanisms. The purpose of this study is to assess the effect of flaxseed on glycemic control in prediabetic adults.

NCT ID: NCT05238012 Completed - Clinical trials for Metabolism Disorder, Glucose

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

XTREME
Start date: August 2, 2022
Phase: Phase 4
Study type: Interventional

This study is a prospective, randomized, open-label, multi-center trial. The primary objective of the study is to assess whether XZK 1200mg/d, compared to atorvastatin 20mg/d, has a favorable impact on HbA1c levels at 24 weeks of treatment in dyslipidemia patients with prediabetes

NCT ID: NCT05235425 Recruiting - PreDiabetes Clinical Trials

The Lifestyle Education About Prediabetes (Leap) Study

LEAP
Start date: March 20, 2022
Phase: N/A
Study type: Interventional

This research will test whether a standard version or very low-carbohydrate version of the Diabetes Prevention Program better improves outcomes like blood glucose control and body weight for patients with prediabetes. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor. Once these enrollment steps are completed and the participants will be randomized to one of two groups: standard National Diabetes Prevention Program (NDPP) or a very low-carbohydrate version. In addition to the diet (12 months) participants will be asked to participate in hour-long weekly group classes over zoom. After four months in the program, classes will occur about every month to help participants maintain the new diet. There will also be check-ins and follow-up visits through out the study.

NCT ID: NCT05230342 Active, not recruiting - Obesity Clinical Trials

Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota

Start date: August 2, 2022
Phase: N/A
Study type: Interventional

This study will investigate whether changes in the intestinal microbiota generated through a nutritional strategy based on functional foods, modifies postprandial glycemic responses in subjects with prediabetes and obesity, which in turn will generate a personalized dietary intervention through a prediction of postprandial blood glucose levels.

NCT ID: NCT05224986 Recruiting - Pre-diabetes Clinical Trials

Lifestyle Patterns and Glycemic Control

Start date: January 19, 2022
Phase: N/A
Study type: Interventional

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.

NCT ID: NCT05217290 Not yet recruiting - PreDiabetes Clinical Trials

The Effect of Health Education Given to Prediabetes Patients by Videoconferencing on Self-management and Exercise

Start date: January 2022
Phase: N/A
Study type: Interventional

The research will be carried out in order to investigate the effect of health education given to prediabetes patients by video conference method on self-management and exercise. The work will be carried out in two stages. In the first stage, the validity and reliability study of the Scale for Process of Exercise Engagement (SPEE) that was developed on prediabetes patients will be conducted and the scale will be adapted to the Turkish society. In the second stage, the effect of health education, which was prepared on the basis of the Transtheoretic Model and will be given by video conferencing, on the exercise status of prediabetes patients, on hunger, postprandial blood sugar, cholesterol, LDL, HDL, triglyceride, blood pressure, HbA1c, BMI, weight, waist circumference measurements will be evaluated. In this research, the exercise change stages dimension of the Transtheoretic Model will be discussed and the trainings will be planned according to these stages.

NCT ID: NCT05216796 Recruiting - Metabolic Syndrome Clinical Trials

Healthy Liver - Healthy Brain

Start date: May 18, 2022
Phase: N/A
Study type: Interventional

People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.

NCT ID: NCT05214209 Active, not recruiting - PreDiabetes Clinical Trials

Diabetes Prevention and Prediabetes Management in Adult

PRIME
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Currently, an estimated 3.9 million Malaysians continue to live with diabetes with many more who live with prediabetes. Diabetes was the one of the leading causes of death in the Malaysia and the leading cause for kidney failure, lower-limb amputations, and adult-onset blindness. Heart disease and stroke are two to four times more likely for individuals with diabetes. The use of mHealth or mobile health application can reduce blood sugar among individuals with prediabetes but also prevent a later occurrence of diabetes. In this study, the investigators aim to develop and evaluate the effectiveness of a digital health supported pre-diabetes management program based in an urban community pharmacy setting

NCT ID: NCT05208424 Completed - Clinical trials for Coronary Artery Disease

New Diabetes Mellitus and Pre-Diabetes With First-time Diagnosed Coronary Artery Disease

DMCAD
Start date: February 27, 2020
Phase:
Study type: Observational [Patient Registry]

A prospective analytic study to evaluate the incidence, clinical and laboratory characteristics, extent of coronary artery disease and short-term outcome of newly diagnosed diabetes and pre-diabetes in patients with first-time diagnosed coronary artery disease treated in Saud Al Babtain Cardiac Center.